Get ahead in your career - track and evidence all your medical learning

New Genentech Drug Targets Cancer's First Line of Defense

Pat Salber (@docweighsin) has a conversation with Alan Sandler MD about Atezolizumab, Genentech's new cancer immunotherapy. Unlike standard chemotherapy, thi...
youtube.com
·
Shared on Thursday 5th November 2015